BeStock  
Stocks › Biotechnology › GMAB

Genmab GMAB

US equityMarket cap rank #546Biotechnology
$34.87 −$0.81 (-2.26%)
Market open · Oct 1, 1:10 pm ET · After hours $35.36 -0.88%
Open$35.28
Prev close$35.68
Day range$34.63 – $35.80
Volume3.59M
Market cap$21.76B
P/E (TTM)27.6
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings28.2x
CheapRich

Around its usual level · 49th percentile, 5-year average 30.2x

#2028 of 2977 stocks by PE (1 = cheapest)

Price / book3.7x
CheapRich

Around its usual level · 43rd percentile, 5-year average 4.8x

#3936 of 5307 stocks by PB (1 = cheapest)

Price / sales5.4x
CheapRich

Below its usual level · 33rd percentile, 5-year average 9.7x

#3938 of 5144 stocks by PS (1 = cheapest)

Morningstar fair value estimate

Fair value$34.94
Price vs. fair value-0.2%Close to the estimate
Star rating★★★☆☆
Economic moatNarrow
UncertaintyMedium
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 3.74 – 4.84 43% (cheaper than usual) #3936 of 5307 (1 = cheapest)
PE 28.20 25.50 30.15 49% (cheaper than usual) #2028 of 2977 (1 = cheapest)
PS 5.39 4.76 9.72 33% (cheaper than usual) #3938 of 5144 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Morningstar view

Star rating★★★
Fair value estimate$34.94
Economic moatNarrow
UncertaintyMedium

Discussion

No comments yet — be the first to weigh in on GMAB.

Leave a comment

Scroll to Top